Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, February, 2006 - Advertising

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive

The following table lists new pharmaceutical account wins notified to us by the winning agencies for the period November 2005 to January 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email nhobson@pmlive.com

 

BD Medical

Portfolio

Regional anaesthesia

Mason Zimbler

Frontier Medical

Repose

Tissue viability

Mason Zimbler

GlaxoSmithKline (Europe)

Integrilin

Cardiovascular

PAN Advertising

GE Healthcare Discovery Systems

New product

N/A

Seven Stones

Genosis

Fertell

Fertility

Dewar Alexander

Gilead Sciences

AmBisome

Antifungal

FCB Healthcare

GrÈnenthal

Clarosip

Antibiotic

MJL Advertising

Janssen-Cilag Ireland

Durogesic D-Trans

Pain relief

MJL Advertising

Menarini

Nebilet

Cardiology

MJL Advertising

Nutricia Clinical Care

Glutafin

Nutrition

Life

Organon

Livial

HRT

PAN Advertising

Organon

Orgaran

Haematology

PAN Advertising

Regent Medical

Website

Hospital-acquired infections

The Foundry

Roche

Tarceva

Oncology

MJL Advertising

Schering AG

Bonefos

Cancer pain

Langland

Zeneus Pharma

N/A

Systemic fungal infections

MJL Advertising

Zeon Healthcare

Krystal Clean Nails

Nail infections

LEC

Zeon Healthcare

ClearZal

Nail infections

LEC

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics